{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:21:30Z","timestamp":1791872490934,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Benzodiazepine receptor agonist (BZRA) use is highly prevalent in hospitalised older people although these drugs are associated with numerous and serious adverse events. Deprescribing can reduce risks associated with chronic BZRA use. The aim of this study was to measure the prevalence of, and factors associated with, BZRA deprescribing in acute geriatric units.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>During a one-year period, this multicentre retrospective study included patients aged \u226570 years, hospitalised in acute geriatric units, and using \u22651 BZRA on admission. BZRA deprescribing at discharge was defined as: \u226525% decrease in lorazepam-equivalent admission dose; discontinuation of all BZRAs; or cessation of a rescue prescription at discharge. BZRA cessation was defined as discontinuation of all BZRAs at discharge. We identified social, medical, geriatric and medication factors associated with BZRA deprescribing using logistic regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 561 patients were included (mean age: 85.3\u00b15.9 years, 70% of women). BZRA deprescribing occurred in 240 (42.8%), including 85 with BZRA cessation (15.2%). Deprescribing occurred more frequently in patients with a BZRA-related adverse event on admission or during hospital stay (odds ratio (OR) 4.5; 95% confidence interval [2.6; 7.9]), with an antidepressant (1.6 [1.1; 2.4]) and a higher lorazepam-equivalent dosage on admission (OR 1.2 [1; 1.4]), and less frequently in patients with antipsychotic drug (OR 0.5 [0.3; 0.8]). BZRA cessation was more likely in patients with a BZRA-related adverse event (OR 2.2 [1.2; 4.3]) and a lower lorazepam-equivalent dosage on admission (OR 0.5 [0.3; 0.6]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>During hospitalisation in the acute geriatric units of our hospital, BZRA deprescribing occurred in 42.8% of the patients. Identification of an BZRA-related adverse event by the treating physician appears to be a major factor: this reactive deprescribing accounted for 74% of cases in our study. Further prospective studies are needed to measure long-term persistence of in-hospital deprescribing and encourage proactive management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-022-02753-w","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T03:04:38Z","timestamp":1643684678000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4173-8581","authenticated-orcid":false,"given":"Fran\u00e7ois-Xavier","family":"Sibille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lor\u00e8ne","family":"Zerah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurentine","family":"Maljean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Schoevaerdts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"de Saint-Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"issue":"Suppl 1","key":"2753_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/pds.3825","volume":"25","author":"C Huerta","year":"2016","unstructured":"Huerta C, Abbing-Karahagopian V, Requena G, Oliva B, Alvarez Y, Gardarsdottir H, et al. Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. 2016;25(Suppl 1):56\u201365.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"2753_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1179\/acb.2006.019","volume":"61","author":"M Petrovic","year":"2006","unstructured":"Petrovic M, Spatharakis G, Conroy S, Van Maeles G, Moulias S. Prevalence of sedative drug use in geriatric in-patients: a multi-centre study. Acta Clin Belg. 2006;61(3):119\u201326.","journal-title":"Acta Clin Belg"},{"issue":"7","key":"2753_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/gps.2189","volume":"24","author":"K Johnell","year":"2009","unstructured":"Johnell K, Fastbom J. The use of benzodiazpines and related drugs amongst older people in Sweden: associated factors and concomitant use of other psychotropics. Int J Geriatr Psychiatry. 2009;24(7):731\u20138.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"2753_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12877-019-1280-2","volume":"19","author":"CM Grossi","year":"2019","unstructured":"Grossi CM, Richardson K, Fox C, Maidment I, Steel N, Loke YK, et al. Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study. BMC Geriatr. 2019;19(1):276.","journal-title":"BMC Geriatr"},{"issue":"n\/a","key":"2753_CR5","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1111\/jgs.16751","volume":"n\/a","author":"P Evrard","year":"2020","unstructured":"Evrard P, Henrard S, Foulon V, Spinewine A. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study. J Am Geriatr Soc. 2020;n\/a(n\/a):2768\u201377.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2753_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.eurger.2016.11.012","volume":"8","author":"JB Beuscart","year":"2017","unstructured":"Beuscart JB, Ficheur G, Miqueu M, Luyckx M, Perichon R, Puisieux F, et al. Co-prescriptions of psychotropic drugs to older patients in a general hospital. Eur Geriatr Med. 2017;8(1):84\u20139.","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"2753_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1179\/acb.2003.58.1.004","volume":"58","author":"M Petrovic","year":"2003","unstructured":"Petrovic M, Mariman A, Warie H, Afschrift M, Pevernagie D. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg. 2003;58(1):27\u201336.","journal-title":"Acta Clin Belg"},{"key":"2753_CR8","first-page":"107","volume":"7","author":"K Sithamparanathan AS","year":"2012","unstructured":"Sithamparanathan AS K, Leung L. Adverse effects of benzodiazepine use in elderly people: A meta-analysis. Asian J Gerontol Geriatr. 2012;7:107\u201311.","journal-title":"Asian J Gerontol Geriatr"},{"issue":"7526","key":"2753_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanct\u00f4t KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ (Clinical research ed). 2005;331(7526):1169.","journal-title":"BMJ (Clinical research ed)"},{"issue":"1","key":"2753_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13311-019-00801-9","volume":"17","author":"LY Tseng","year":"2020","unstructured":"Tseng LY, Huang ST, Peng LN, Chen LK, Hsiao FY. Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use. Neurotherapeutics. 2020;17(1):156\u201364.","journal-title":"Neurotherapeutics"},{"key":"2753_CR11","doi-asserted-by":"crossref","unstructured":"Panel BtAGSBCUE. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674\u201394.","DOI":"10.1111\/jgs.15767"},{"issue":"6","key":"2753_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/ageing\/afn197","volume":"37","author":"P Gallagher","year":"2008","unstructured":"Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008;37(6):673\u20139.","journal-title":"Age Ageing"},{"issue":"5","key":"2753_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s40266-019-00669-6","volume":"36","author":"F Pazan","year":"2019","unstructured":"Pazan F, Weiss C, Wehling M. The FORTA (Fit fOR The Aged) List 2018: Third Version of a Validated Clinical Tool for Improved Drug Treatment in Older People. Drugs Aging. 2019;36(5):481\u20134.","journal-title":"Drugs Aging"},{"issue":"6","key":"2753_CR14","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging de fi nition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254\u201368.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"2753_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40266-018-0544-4","volume":"35","author":"BJ Ng","year":"2018","unstructured":"Ng BJ, Le Couteur DG, Hilmer SN. Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients. Drugs Aging. 2018;35(6):493\u2013521.","journal-title":"Drugs Aging"},{"issue":"3","key":"2753_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/bcpt.13144","volume":"124","author":"R L\u00e4hteenm\u00e4ki","year":"2019","unstructured":"L\u00e4hteenm\u00e4ki R, Neuvonen PJ, Puustinen J, Vahlberg T, Partinen M, R\u00e4ih\u00e4 I, et al. Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia. Basic Clin Pharmacol Toxicol. 2019;124(3):330\u201340.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"2753_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00228-013-1613-6","volume":"70","author":"J Puustinen","year":"2014","unstructured":"Puustinen J, L\u00e4hteenm\u00e4ki R, Polo-Kantola P, Salo P, Vahlberg T, Lyles A, et al. Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults. Eur J Clin Pharmacol. 2014;70(3):319\u201329.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"2753_CR18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1517\/14740338.2014.925444","volume":"13","author":"AM Paquin","year":"2014","unstructured":"Paquin AM, Zimmerman K, Rudolph JL. Risk versus risk: a review of benzodiazepine reduction in older adults. Expert Opin Drug Saf. 2014;13(7):919\u201334.","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"2753_CR19","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1017\/S0033291703008213","volume":"33","author":"HV Curran","year":"2003","unstructured":"Curran HV, Collins R, Fletcher S, Kee SC, Woods B, Iliffe S. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med. 2003;33(7):1223\u201337.","journal-title":"Psychol Med"},{"issue":"3","key":"2753_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/ageing\/afp255","volume":"39","author":"M Salonoja","year":"2010","unstructured":"Salonoja M, Salminen M, Aarnio P, Vahlberg T, Kivela SL. One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons. Age Ageing. 2010;39(3):313\u20139.","journal-title":"Age Ageing"},{"issue":"6","key":"2753_CR21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Internal Med. 2014;174(6):890\u20138.","journal-title":"JAMA Internal Med"},{"issue":"10","key":"2753_CR22","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00228-014-1725-7","volume":"70","author":"J Bourgeois","year":"2014","unstructured":"Bourgeois J, Elseviers MM, Van Bortel L, Petrovic M, Vander Stichele RH. Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study. Eur J Clin Pharmacol. 2014;70(10):1251\u201360.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"2753_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/(SICI)1099-1166(199909)14:9<754::AID-GPS15>3.0.CO;2-E","volume":"14","author":"M Petrovic","year":"1999","unstructured":"Petrovic M, Pevernagie D, Van Den Noortgate N, Mariman A, Michielsen W, Afschrift M. A programme for short-term withdrawal from benzodiazepines in geriatric hospital inpatients: success rate and effect on subjective sleep quality. Int J Geriatr Psychiatry. 1999;14(9):754\u201360.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"11","key":"2753_CR24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00228-001-0387-4","volume":"57","author":"M Petrovic","year":"2002","unstructured":"Petrovic M, Pevernagie D, Mariman A, Van Maele G, Afschrift M. Fast withdrawal from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial. Eur J Clin Pharmacol. 2002;57(11):759\u201364.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2753_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/jcpt.12688","volume":"43","author":"L Djatche","year":"2018","unstructured":"Djatche L, Lee S, Singer D, Hegarty SE, Lombardi M, Maio V. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing? J Clin Pharmacy Therapeutics. 2018;43(4):550\u20135.","journal-title":"J Clin Pharmacy Therapeutics"},{"issue":"1","key":"2753_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12877-020-01843-x","volume":"20","author":"Z Rozsnyai","year":"2020","unstructured":"Rozsnyai Z, Jungo KT, Reeve E, Poortvliet RKE, Rodondi N, Gussekloo J, et al. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey. BMC Geriatr. 2020;20(1):435.","journal-title":"BMC Geriatr"},{"key":"2753_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12877-016-0181-x","volume":"16","author":"A Palagyi","year":"2016","unstructured":"Palagyi A, Keay L, Harper J, Potter J, Lindley RI. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care. BMC Geriatr. 2016;16:15.","journal-title":"BMC Geriatr"},{"issue":"10","key":"2753_CR28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","volume":"30","author":"E Reeve","year":"2013","unstructured":"Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793\u2013807.","journal-title":"Drugs Aging"},{"issue":"3","key":"2753_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0165-1781(92)90005-N","volume":"41","author":"MD Miller","year":"1992","unstructured":"Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992;41(3):237\u201348.","journal-title":"Psychiatry Res"},{"issue":"6","key":"2753_CR30","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s11606-019-04899-7","volume":"34","author":"JL Holleck","year":"2019","unstructured":"Holleck JL, Merchant N, Gunderson CG. Symptom-Triggered Therapy for Alcohol Withdrawal Syndrome: a Systematic Review and Meta-analysis of Randomized Controlled Trials. J Gen Intern Med. 2019;34(6):1018\u201324.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"2753_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1684\/epd.2018.0987","volume":"20","author":"SK Rao","year":"2018","unstructured":"Rao SK, Mahulikar A, Ibrahim M, Shah A, Seraji-Bozorgzad N, Mohamed W. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus. Epileptic Disord. 2018;20(4):265\u20139.","journal-title":"Epileptic Disord"},{"issue":"3","key":"2753_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s11096-014-9940-y","volume":"36","author":"LD Jensen","year":"2014","unstructured":"Jensen LD, Andersen O, Hallin M, Petersen J. Potentially inappropriate medication related to weakness in older acute medical patients. Int J Clin Pharm. 2014;36(3):570\u201380.","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"2753_CR33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00228-015-1837-8","volume":"71","author":"J D\u00edez-Manglano","year":"2015","unstructured":"D\u00edez-Manglano J, Gim\u00e9nez-L\u00f3pez M, Garc\u00e9s-Horna V, Sevil-Puras M, Castellar-Ot\u00edn E, Gonz\u00e1lez-Garc\u00eda P, et al. Excessive polypharmacy and survival in polypathological patients. Eur J Clin Pharmacol. 2015;71(6):733\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"2753_CR34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2165\/11584480-000000000-00000","volume":"27","author":"J Joester","year":"2010","unstructured":"Joester J, Vogler CM, Chang K, Hilmer SN. Hypnosedative use and predictors of successful withdrawal in new patients attending a falls clinic: a retrospective, cohort study. Drugs Aging. 2010;27(11):915\u201324.","journal-title":"Drugs Aging"},{"issue":"2","key":"2753_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11096-019-00797-4","volume":"41","author":"T Aoki","year":"2019","unstructured":"Aoki T, Yamamoto Y, Ikenoue T, Fukuhara S. Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications. Int J Clin Pharm. 2019;41(2):531\u20137.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"2753_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1590\/S0102-311X2009000300015","volume":"25","author":"JM Alvarenga","year":"2009","unstructured":"Alvarenga JM, Loyola Filho AI, Firmo JO, Lima-Costa MF, Uchoa E. A population based study on health conditions associated with the use of benzodiazepines among older adults (The Bambu\u00ed Health and Aging Study). Cad Saude Publica. 2009;25(3):605\u201312.","journal-title":"Cad Saude Publica"},{"key":"2753_CR37","doi-asserted-by":"publisher","first-page":"106195","DOI":"10.1016\/j.addbeh.2019.106195","volume":"102","author":"A Allary","year":"2020","unstructured":"Allary A, Proulx-Tremblay V, B\u00e9langer C, Hudon C, Marchand A, O'Connor K, et al. Psychological predictors of benzodiazepine discontinuation among older adults: Results from the PASSE 60. Addict Behav. 2020;102:106195.","journal-title":"Addict Behav"},{"issue":"2","key":"2753_CR38","first-page":"163","volume":"9","author":"AL Couderc","year":"2011","unstructured":"Couderc AL, Bailly-Agaledes C, Camalet J, Capriz-Ribi\u00e8re F, Gary A, Robert P, et al. Adaptations of psychotropic drugs in patients aged 75 years and older in a departement of geriatric internal medecine: report of 100 cases. Geriatr Psychol Neuropsychiatr Vieil. 2011;9(2):163\u201370.","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"issue":"10","key":"2753_CR39","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/j.1532-5415.2008.01935.x","volume":"56","author":"F Salvi","year":"2008","unstructured":"Salvi F, Miller MD, Grilli A, Giorgi R, Towers AL, Morichi V, et al. A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc. 2008;56(10):1926\u201331.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2753_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1447-0594.2008.00462.x","volume":"8","author":"RM Clements","year":"2008","unstructured":"Clements RM. Reducing psychotropic medications in elderly rehabilitation inpatients with a fall-related admission: how often is it happening? Geriatr Gerontol Int. 2008;8(3):139\u201342.","journal-title":"Geriatr Gerontol Int"},{"issue":"6","key":"2753_CR41","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/jgs.15300","volume":"66","author":"MG Wilson","year":"2018","unstructured":"Wilson MG, Lee TC, Hass A, Tannenbaum C, McDonald EG. EMPOWERing Hospitalized Older Adults to Deprescribe Sedative Hypnotics: A Pilot Study. J Am Geriatr Soc. 2018;66(6):1186\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"2753_CR42","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s11096-018-0673-1","volume":"40","author":"S Scott","year":"2018","unstructured":"Scott S, Clark A, Farrow C, May H, Patel M, Twigg MJ, et al. Deprescribing admission medication at a UK teaching hospital; a report on quantity and nature of activity. Int J Clin Pharm. 2018;40(5):991\u20136.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"2753_CR43","first-page":"Cd011481","volume":"3","author":"L Baandrup","year":"2018","unstructured":"Baandrup L, Ebdrup BH, Rasmussen J, Lindschou J, Gluud C, Glenth\u00f8j BY. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. Cochrane Database Syst Rev. 2018;3(3):Cd011481.","journal-title":"Cochrane Database Syst Rev"},{"issue":"18","key":"2753_CR44","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.16131","volume":"320","author":"P Martin","year":"2018","unstructured":"Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial. JAMA. 2018;320(18):1889\u201398.","journal-title":"JAMA"},{"issue":"1","key":"2753_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11096-019-00784-9","volume":"41","author":"N Ailabouni","year":"2019","unstructured":"Ailabouni N, Mangin D, Nishtala PS. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm. 2019;41(1):167\u201378.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"2753_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jgs.15623","volume":"67","author":"CA Ammerman","year":"2019","unstructured":"Ammerman CA, Simpkins BA, Warman N, Downs TN. Potentially Inappropriate Medications in Older Adults: Deprescribing with a Clinical Pharmacist. J Am Geriatr Soc. 2019;67(1):115\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2753_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/ageing\/afv190","volume":"45","author":"KA Walsh","year":"2016","unstructured":"Walsh KA, O'Riordan D, Kearney PM, Timmons S, Byrne S. Improving the appropriateness of prescribing in older patients: a systematic review and meta-analysis of pharmacists' interventions in secondary care. Age Ageing. 2016;45(2):201\u20139.","journal-title":"Age Ageing"},{"issue":"3","key":"2753_CR48","doi-asserted-by":"publisher","first-page":"e000539","DOI":"10.1136\/bmjoq-2018-000539","volume":"8","author":"F Carr","year":"2019","unstructured":"Carr F, Tian P, Chow J, Guzak J, Triscott J, Mathura P, et al. Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative. BMJ Open Qual. 2019;8(3):e000539.","journal-title":"BMJ Open Qual"},{"issue":"3","key":"2753_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4212\/cjhp.v73i3.2997","volume":"73","author":"HL Neville","year":"2020","unstructured":"Neville HL, Losier M, Pitman J, Gehrig M, Isenor JE, Minard LV, et al. Point Prevalence Survey of Benzodiazepine and Sedative-Hypnotic Drug Use in Hospitalized Adult Patients. Canadian J Hosp Pharmacy. 2020;73(3):193\u2013201.","journal-title":"Canadian J Hosp Pharmacy"},{"issue":"8","key":"2753_CR50","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00228-019-02668-3","volume":"75","author":"F Wedmann","year":"2019","unstructured":"Wedmann F, Himmel W, Nau R. Medication and medical diagnosis as risk factors for falls in older hospitalized patients. Eur J Clin Pharmacol. 2019;75(8):1117\u201324.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"2753_CR51","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11096-007-9097-z","volume":"29","author":"P Fagnoni","year":"2007","unstructured":"Fagnoni P, Limat S, Haffen E, Henon T, Jacquet M, Sechter D, et al. Does hospitalisation affect hypnotic and anxiolytic drug prescribing? Pharm World Sci. 2007;29(6):611\u20138.","journal-title":"Pharm World Sci"},{"issue":"5","key":"2753_CR52","first-page":"339","volume":"64","author":"K Pottie","year":"2018","unstructured":"Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists. Evid Based Clin Pract Guideline. 2018;64(5):339\u201351.","journal-title":"Evid Based Clin Pract Guideline"},{"issue":"1","key":"2753_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jgs.16157","volume":"68","author":"P Goyal","year":"2020","unstructured":"Goyal P, Anderson TS, Bernacki GM, Marcum ZA, Orkaby AR, Kim D, et al. Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults. J Am Geriatr Soc. 2020;68(1):78\u201386.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2753_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/bcp.14595","volume":"87","author":"S Scott","year":"2021","unstructured":"Scott S, Wright DJ, Bhattacharya D. The role of behavioural science in changing deprescribing practice. Br J Clin Pharmacol. 2021;87(1):39\u201341.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2753_CR55","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s13063-020-04482-0","volume":"21","author":"EA Bayliss","year":"2020","unstructured":"Bayliss EA, Shetterly SM, Drace ML, Norton J, Green AR, Reeve E, et al. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Trials. 2020;21(1):542.","journal-title":"Trials"},{"key":"2753_CR56","doi-asserted-by":"crossref","first-page":"204209861881656","DOI":"10.1177\/2042098618816562","volume":"10","author":"D Gnjidic","year":"2019","unstructured":"Gnjidic D, Ong HMM, Leung C, Jansen J, Reeve E. The impact of in hospital patient-education intervention on older people's attitudes and intention to have their benzodiazepines deprescribed: a feasibility study. Therapeutic Adv Drug Saf. 2019;10:2042098618816562.","journal-title":"Therapeutic Adv Drug Saf"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-022-02753-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-022-02753-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-022-02753-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T15:03:53Z","timestamp":1666623833000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-022-02753-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2753"],"URL":"https:\/\/doi.org\/10.1186\/s12877-022-02753-w","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"1 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the declaration of Helsinki. This study received the approval of the local ethical committees of the CHU UCL Namur (Ethic committee of CHU UCL Namur (Dinant, OM110): 01-2019; Ethic committee CHU UCL Namur (Godinne, OM039): B039201940248; Ethic committee of CHU UCL Namur (Sainte-Elisabeth, OM070): 13-19). The informed consent of patients was not required because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}